Safety and Efficacy of Renuvion Helium Plasma to Improve the Appearance of Loose Skin in the Neck and Submental Region.
PMID : 36883611 ·
P, a, u, l, , G, , R, u, f, f, ;, , G, a, u, r, a, v, , B, h, a, r, t, i, ;, , J, o, s, e, p, h, , H, u, n, s, t, a, d, ;, , B, i, l, l, , K, o, r, t, e, s, i, s, ;, , B, a, r, r, y, , D, i, B, e, r, n, a, r, d, o, ;, , R, i, c, h, a, r, d, , G, e, n, t, i, l, e, ;, , S, t, e, v, e, n, , C, o, h, e, n, ;, , A, l, l, i, s, o, n, , M, a, r, t, i, n, e, z, ;, , S, a, c, h, i, n, , M, , S, h, r, i, d, h, a, r, a, n, i
Publicité
Résumé
Minimally invasive procedures that deliver thermal energy to subcutaneous tissue offer a solution when deciding between excisional and noninvasive options to address face and neck aging-related changes. A minimally invasive helium plasma device, Renuvion, was first utilized for subdermal tissue heating to reduce skin laxity under an FDA general clearance for cutting, coagulation, and ablation of soft tissue. The purpose of this study was to demonstrate the safety and effectiveness of the helium
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.